Elhence R et al (1994) studied on 13 patients with steroid-resistant INS with minimal change and compared the efficacy of oral and intravenous cyclophosphamide. The results showed that the remission rate in the group receiving intravenous cyclophosphamide (100%) was much higher than that in the remaining group receiving oral cyclophosphamide (25%).